Action of solamargine on human lung cancer cells - enhancement of the susceptibility of cancer cells to TNFs

被引:79
|
作者
Liu, LF
Liang, CH
Shiu, LY
Lin, WL
Lin, CC
Kuo, KW
机构
[1] I Shou Univ, Dept Med Radiat Technol, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Sch Med, Dept Biochem, Kaohsiung 807, Taiwan
关键词
solamargine; drug resistance; lung cancer; apoptosis;
D O I
10.1016/j.febslet.2004.09.064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Solamargine (SM), isolated from Solanum incanum herb, displayed a superior cytotoxicity in four human lung cancer cell lines. The half-inhibitory concentrations (IC50), of the cell viability assay for H441, H520, H661 and H69 cells were 3, 6.7, 7.2 and 5.8 muM, respectively. SM-induced apoptosis of these cells by PS externalization in a dose-dependent manner and increased sub-G, fraction were observed. Quenching of the expression of tumor necrosis factor receptors (TNFRs) during the progress of human lung carcinogenesis has been previously reported. SM may induce cell apoptosis via modulating the expression of TNFRs and their subsequent TRADD/FADD signal cascades. Subsequently, SM treatment increased the binding activities of TNF-alpha and TNF-beta to the lung cancers, and the intrinsic TNFs-resistant cancer cells became susceptible to TNF-alpha and -beta. In addition, SM caused release of cytochrome c, downregulation of anti-apoptotic Bcl-2 and BCI-x(L), increase of caspase-3 activity, and DNA fragmentation. Thus, SM could modulate the expressions of TNFRs and Bcl-2, and might be a potential anticancer agent for TNFs and Bcl-2 related resistance of human lung cancer cells. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 74
页数:8
相关论文
共 50 条
  • [31] ELECTRON MICROSCOPIC STUDIES ON HUMAN LUNG CANCER CELLS
    HATTORI, S
    MATSUDA, M
    TATEISHI, R
    TERAZAWA, T
    GANN, 1967, 58 (03): : 283 - +
  • [32] CLONOGENICITY OF HUMAN-LUNG CANCER-CELLS
    TWENTYMAN, P
    WALLS, G
    BRITISH JOURNAL OF CANCER, 1984, 50 (02) : 275 - 276
  • [33] Proteomic profiling of endothelial cells in human lung cancer
    Park, Hye-Jeong
    Kim, Byung-Gyu
    Lee, Seung-Jin
    Heo, Sun-Hee
    Kim, Jae-Young
    Kwon, Tae-Hwan
    Lee, Eung-Bae
    Ryoo, Hyun-Mo
    Cho, Je-Yoel
    JOURNAL OF PROTEOME RESEARCH, 2008, 7 (03) : 1138 - 1150
  • [34] Rank is expressed in human lung tumors and is functional on human lung cancer cells
    Tometsko, M.
    Miller, R.
    Dougall, W.
    Chaisson, M.
    CANCER TREATMENT REVIEWS, 2006, 32 : S45 - S45
  • [35] DETECTION OF THROMBOMODULIN IN HUMAN LUNG-CANCER CELLS
    TAMURA, A
    MATSUBARA, O
    HIROKAWA, K
    AOKI, N
    AMERICAN JOURNAL OF PATHOLOGY, 1993, 142 (01): : 79 - 85
  • [36] CLONOGENIC ABILITY OF HUMAN LUNG-CANCER CELLS
    SERGEEVA, NS
    MOROZ, IA
    SVIRIDOVA, IK
    CHISSOV, VI
    EKSPERIMENTALNAYA ONKOLOGIYA, 1990, 12 (05): : 56 - 59
  • [37] ENHANCEMENT OF CYTOTOXIC DRUG-ACTION ON GROWTH OF HUMAN BREAST-CANCER CELLS BY MEDROXYPROGESTERONE ACETATE
    REED, MJ
    GHILCHIK, MW
    BRAUNSBERG, H
    SHAIKH, NA
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 174 - 174
  • [38] Enhancement of Doxorubicin Cytotoxicity by Verapamil in Human Breast Cancer Cells
    Al-harthy, Sameer E.
    Al-Motairi, Mashael S.
    Al-Kreathy, Huda M.
    Kamel, Fatemah O.
    Sayed-Ahmed, Mohamed M.
    Huwait, Etimad Abbas
    Al-Malkey, Hamdan S.
    Osman, Abdel-Moneim M.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2019, 27 (06)
  • [39] ENHANCEMENT OF SENSITIVITY TO HYPERTHERMIA BY LONIDAMINE IN HUMAN CANCER-CELLS
    RAAPHORST, GP
    FEELEY, MM
    MARTIN, L
    DANJOUX, CE
    MAROUN, J
    DESANCTIS, AJ
    KO, D
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1991, 7 (05) : 763 - 772
  • [40] Enhancement of radiosensitivity by combined ceramide and dimethylsphingosine treatment in lung cancer cells
    Hye-Won Park
    Jie-Young Song
    Ki-Sung Kim
    Youngsoo Han
    Chan-Wha Kim
    Seh-Yoon Yi
    Yeon-Sook Yun
    Experimental & Molecular Medicine, 2004, 36 : 411 - 419